DOCSLIB.ORG

Gene Symbol Species Protein Accession

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Gene Symbol Species Protein Accession Protein Names Protein (Fc chimera proteins are not compatible Gene Symbol Species Accession # with anti-IgG secondary antibodies) 2B4/CD244/SLAMF4 , *Fc Chimera CD244 2B4 Mouse Q07763 4-1BB/TNFRSF9 , *Fc Chimera TNFRSF9 Mouse P20334 ACE ACE DCP DCP1 Mouse P09470 ACE-2 ACE2 UNQ868/PRO1885 Mouse NP_081562 Activin A INHBA Mouse P08476 ADAMTS1 ADAMTS1 Mouse P97857 ADIPOQ ACDC ACRP30 Adiponectin/Acrp30 Mouse Q60994 APM1 GBP28 AgRP C-Terminal Fragment AGRP AGRT ART Mouse NP_031453 ALCAM , *Fc Chimera ALCAM MEMD Mouse Q61490 ALK-1 , *Fc Chimera SLPI WAP4 WFDC4 Mouse P97430 AMICA1 JAML AMICA , *Fc Chimera Mouse Q80UL9 UNQ722/PRO1387 Amphiregulin AREG SDGF; AREGB Mouse P31955 Angiogenin, Ribonuclease ANG Mouse P21570 Angiopoietin-2 ANGPT2 Mouse NP_031452 ANGPTL3 ANGPT5 Angiopoietin-like 3 Mouse Q9R182 UNQ153/PRO179 Angiopoietin-like 4 ANGPTL4 ARP4 Mouse Q9Z1P8 Artemin ARTN EVN Mouse Q9Z0L2 Axl , *Fc Chimera AXL UFO Mouse Q00993 CD80 CD28LG CD28LG1 B7-1/CD80 , *Fc Chimera Mouse Q00609 LAB7 BAFF R/TNFRSF13C , *Fc Chimera TNFRSF13C BAFFR BR3 Mouse Q9D8D0 BAFF/BLyS/TNFSF13B TNFSF13B BAFF BLYS Mouse Q9WU72 BCAM , *Fc Chimera BCAM LU MSK19 Mouse Q9R069 BCL2-like 11 BCL2L11 Mouse Q6PEB3 BCMA/TNFRSF17 , *Fc Chimera TNFRSF17 BCM BCMA Mouse O88472 Beta IG-H3 TGFBI BIGH3 Mouse P82198 Betacellulin BTC Mouse Q05928 Beta-NGF NGF NGFB Mouse P01139 Bid BID Mouse P70444 Birc3, baculoviral IAP repeat-containing 3 BIRC3 Mouse Q921N0 Birc5, baculoviral IAP repeat-containing 5 BIRC5 Mouse O70201 BMP-2 BMP2 BMP2A Mouse P12643 BMP-4 BMP4 BMP2B DVR4 Mouse P21275 BMP-5 BMP5 Mouse P49003 BMP-6 BMP6 VGR Mouse P20722 BMP-7 BMP7 OP1 Mouse P23359 BMP-9 GDF2 BMP9 Mouse Q9WV56 BMPR-II , *Fc Chimera BMPR2 PPH1 Mouse Q13873 Cardiotrophin-1 (CT-1) CTF1 Mouse Q60753 Cathepsin B CTSB CPSB Mouse P10605 CCL11/Eotaxin CCL11 SCYA11 Mouse P48298 CCL12/MCP-5 CCL12 MCP5 SCYA12 Mouse Q62401 CCL19/MIP-3 beta CCL19 ELC MIP3B SCYA19 Mouse O70460 CCL2/JE/MCP-1 CCL2 SCYA2 Mouse P10148 CCL20/MIP-3 alpha CCL20 LARC MIP3A SCYA20 Mouse O89093 CCL21 SCYA21 CCL21/6Ckine Mouse P86792 UNQ784/PRO1600 CCL22 MDC SCYA22 A- CCL22/MDC Mouse O88430 152E5.1 CCL24/Eotaxin-2/MPIF-2 (aa 24-119) CCL24 MPIF2 SCYA24 Mouse Q9JKC0 CCL25/TECK CCL25 SCYA25 TECK Mouse O35903 CCL27/CTACK CCL27 ILC SCYA27 Mouse Q9Z1X0 CCL28 CCL28 SCYA28 Mouse Q9JIL2 CCL4/MIP-1 beta CCL4 Mouse P14097 CCL5/RANTES CCL5 SCYA5 Mouse P30882 CCL6/C10 CCL6 C10 SCYA6 Mouse P27784 CCL9/10/MIP-1 gamma CCL9 MRP2 SCYA10 SCYA9 Mouse P51670 CD27 Ligand/TNFSF7 CD70 Mouse Q05A52 CD27/TNFRSF7 , *Fc Chimera CD27 TNFRSF7 Mouse P41272 CD30 Ligand/TNFSF8 TNFSF8 CD30L CD30LG Mouse P32972 CD30/TNFRSF8 , *Fc Chimera TNFRSF8 CD30 D1S166E Mouse Q60846 CD31/PECAM-1 PECAM1 Mouse Q08481 CD36/SR-B3 , *Fc Chimera CD36 Mouse Q08857 CD40/TNFRSF5 , *Fc Chimera CD40 TNFRSF5 Mouse P27512 CD48/SLAMF2 CD48 BCM1 BLAST1 Mouse P18181 CD6 , *Fc Chimera CD6 Mouse Q61003 Chemerin (aa 17-156) RARRES2 TIG2 Mouse Q9DD06 Chitinase 3-like 1 CHI3L1 Mouse Q61362 Chordin CHRD Mouse Q9Z0E2 Clusterin CLU APOJ CLI KUB1 AAG4 Mouse Q06890 Coagulation Factor III/Tissue Factor F3 Mouse P20352 Complement Component C5a C5 CPAMD4 Mouse P06684 C-Reactive /CRP CRP PTX1 Mouse P14847 CTLA-4 , *Fc Chimera CTLA4 CD152 Mouse P09793 CUB domain-containing 1 CDCP1 Mouse Q5U462 CX3CL1 FKN NTT SCYD1 A- CX3CL1/Fractalkine (Full Length) Mouse P12850 152E5.2 CXCL10 CRG2 IFI10 INP10 CXCL10/IP-10/CRG-2 Mouse P17515 SCYB10 CXCL11 ITAC SCYB11 CXCL11/I-TAC Mouse Q9JHH5 SCYB9B CXCL12/SDF-1 alpha CXCL12 SDF1 SDF1A SDF1B Mouse P40224 CXCL13/BLC/BCA-1 CXCL13 BCA1 BLC SCYB13 Mouse O55038 CXCL15/Lungkine CXCL15 SCYB15 Mouse Q9WVL7 CXCL16 SCYB16 SRPSOX CXCL16 Mouse Q8BSU2 UNQ2759/PRO6714 CXCL4/PF4 PF4 CXCL4 SCYB4 Mouse Q9Z126 CXCL7/Thymus Chemokine-1 (aa 48-109) PPBP CXCL7 MCG_1702 Mouse Q9EQI5 CXCL9/MIG CXCL9 Mouse P18340 Cystatin C CST3 Mouse P21460 DAN PARN DAN Mouse Q8VDG3 Decorin DCN Mouse P28654 Diablo DIABLO Mouse BC054109 Dkk-1 DKK1 UNQ492/PRO1008 Mouse O54908 DLL4 DLL4 Mouse Q9JI71 DPPIV/CD26 DPP4 ADCP2 CD26 Mouse P28843 Dtk/Tyrosine- kinase receptor TYRO3 , *Fc TYRO3 Mouse P55144 Chimera E-Cadherin , *Fc Chimera CDH1 CDHE UVO Mouse P09803 EDAR , *Fc Chimera EDAR DL Mouse Q9R187 EGF EGF Mouse P01132 EGF R/ErbB1 , *Fc Chimera EGFR Mouse Q01279 Endocan ESM1 Mouse Q9QYY7 Endoglin/CD105 , *Fc Chimera ENG END Mouse Q63961 Endostatin COL18A1 Mouse P39061 Epigen EPGN Mouse Q924X1 Epiregulin EREG Mouse Q61521 ErbB3/Her3 , *Fc Chimera ERBB3 Mouse Q61526 Erythropoietin EPOR Mouse P07321 E-Selectin/CD62E , *Fc Chimera SELE ELAM1 Mouse Q00690 FASLG APT1LG1 CD95L FASL Fas Ligand/TNFSF6 Mouse P41047 TNFSF6 Fc gamma RIIB/CD32b FCGR2 FCGR2B Mouse NP_034317 Fetuin A/AHSG AHSG FETUA PRO2743 Mouse P29699 FGF acidic FGF1 Mouse P61148 FGF-4 FGF4 HST HSTF1 KS3 Mouse P11403 FGF-6 FGF6 HST2 HSTF2 Mouse NP_034334 FGF-9 FGF9 Mouse NP_037084 Fibroblast Growth Factor 21, FGF-21 FGF21 Mouse Q9JJN1 Flt-3 Ligand FLT3LG Mouse P49772 Furin FURIN FUR PACE PCSK3 Mouse P23188 Galectin-1 LGALS1 Mouse P16045 Galectin-3 LGALS3 Mouse Q8C253 Galectin-7 LGALS7 PIG1; LGALS7B Mouse Q9CRB1 Gas1 GAS1 Mouse Q01721 Gas6 GAS6 AXLLG Mouse Q61592 G-CSF CSF3 C17ORF33 GCSF Mouse P09920 GDF-11/BMP-11 GDF11 Mouse O95390 GDF-8/Myostatin GDF6 BMP13 GDF16 Mouse Q6KF10 TNFSF18 AITRL GITRL TL6 GITR Ligand/TNFSF18 (aa 47-173) Mouse Q7TS55 UNQ149/PRO175 TNFRSF18 AITR GITR GITR/TNFRSF18 , *Fc Chimera Mouse O35714 UNQ319/PRO364 GM-CSF CSF2 Mouse P26955 GZMB CGL1 CSPB CTLA1 Granzyme B Mouse P11033 GRB Gremlin GREM1 CKTSF1B1 DRM Mouse O70326 H60 , *Fc Chimera H60A H60 Mouse Q3TDZ7 SPINT1 HAI1 HAI-1 Mouse Q9R097 UNQ223/PRO256 HGF MET Mouse Q08048 HGF R/c-MET , *Fc Chimera MET Mouse P16056 ICAM-1/CD54 , *Fc Chimera ICAM1 Mouse P13597 IFN-gama IFNG Mouse P01580 IFN-gamma R1 , *Fc Chimera IFNGR1 Mouse P15261 IGFBP-1 IGFBP1 IBP1 Mouse P47876 IGFBP-2 IGFBP2 Mouse P47877 IGFBP-3 IGFBP3 IBP3 Mouse P47878 IGFBP-4 IGFBP4 IBP4 Mouse P47879 IGFBP-5 IGFBP5 IBP5 Mouse Q07079 IGFBP-6 IGFBP6 IBP6 Mouse P47880 IGF-I IGF1 Mouse P05017 IGF-I R IGF1R Mouse Q60751 IGF-II IGF2 PP1446 Mouse P09535 IL-1 alpha/IL-1F1 IL1A Mouse P01582 IL-1 beta IL1B Mouse P10749 IL-1 RI , *Fc Chimera IL1R1 IL1R IL1RA IL1RT1 Mouse P13504 IL-1 RII , *Fc Chimera IL1R2 IL1RB Mouse Q4FK69 IL-10 IL10 Mouse P18893 IL-11 IL11 Mouse P47873 IL-12 IL12B IL12A Mouse P43432 (p40) & P43431 (p35) IL-12/IL-23 p40 Homodimer IL12B Mouse P43432 IL-13 IL13 Mouse P20109 IL-15 IL15 Mouse P48346 IL-16 IL16 Mouse O54824 IL-17A IL17A Mouse Q62386 IL17B IL20 NIRF ZCYTO7 IL-17B Mouse Q9QXT6 UNQ516/PRO1031 IL25 IL17E IL-17E Mouse Q8VHH8 UNQ3120/PRO10272 IL-17F IL17F Mouse Q7TNI7 IL-1ra/IL-1F3 IL1RN IL1RA Mouse P25085 IL-2 IL2 IL-2 Mouse P04351 IL20 ZCYTO10 IL-20 Mouse Q9JKV9 UNQ852/PRO1801 IL-21 IL21 Mouse E9PX58 IL22 ILTIF ZCYTO18 IL-22 Mouse Q9JJY9 UNQ3099/PRO10096 IL-27 subunit alpha IL27 IL27A IL30 Mouse Q8K3I6 IL-28B/IFN-lambda 3 IFNL2 IL28A ZCYTO20 Mouse Q4VK74 IL-2R alpha, CD25 IL2RA Mouse P01590 IL-3 IL3 Mouse P01586 IL-33 IL33 C9ORF26 IL1F11 NFHEV Mouse Q8BVZ5 IL-36 alpha/IL-1F6 IL36A FIL1E IL1E IL1F6 Mouse NP_062323 IL-36 beta/IL-1F8 IL36B IL1F8 IL1H2 Mouse Q9D6Z6 IL36G IL1E IL1F9 IL1H1 IL-36 gamma/IL-1F9 (aa 13-164) Mouse Q8R460 IL1RP2 IL-4 IL4 Mouse P07750 IL-5 IL5 Mouse P04401 IL-6 IL6 Mouse P08505 IL-6R alpha (aa 20-357) IL6R Mouse P22272 IL-6R beta, *Fc Chimera IL6ST Mouse Q00560 IL-7 IL7 Mouse P10168 IL-7 R alpha/CD127 , *Fc Chimera IL7R Mouse Q9R0C1 IL-9 IL9 Mouse P15247 F11R JAM1 JCAM JAM-A , *Fc Chimera Mouse O88792 UNQ264/PRO301 KGF/FGF-7 FGF7 EGK_17479 Mouse P36363 Kremen-1 KREMEN1 Mouse Q99N43 Leptin LEP OB OBS Mouse P41160 Leptin R , *Fc Chimera LEPR DB OBR Mouse P48356 LIF, Differentiation-stimulating factor, D LIF Mouse P09056 factor. Limitin/IFN-zeta N/A Mouse Q9R1T0 Lipocalin-2/NGAL LCN2 HNL NGAL Mouse P11672 LIX CXCL5 SCYB5 Mouse P50228 LOX-1/OLR1 OLR1 CLEC8A LOX1 Mouse Q9EQ09 L-Selectin/CD62L , *Fc Chimera SELL LNHR LYAM1 Mouse Q3TCF3 LYVE1 CRSBP1 HAR XLKD1 LYVE-1 Mouse Q8BHC0 UNQ230/PRO263 MAdCAM-1 , *Fc Chimera MADCAM1 Mouse Q61826 MBL-2 MBL2 Mouse P41317 M-CSF CSF1 Mouse P07141 Meteorin METRN HYRAC Mouse Q8C1Q4 MFG-E8 MFGE8 Mouse P21956 MIF MIF Mouse P34884 MIP-1 alpha CCL3 Mouse P10855 MIP-2 CXCL2 MIP-2 MIP2 SCYB2 Mouse P10889 MMP-10 MMP10 Mouse O55123 MMP-2 MMP2 CLG4A Mouse P33434 MMP-20 MMP20 Mouse P57748 MMP-3 MMP3 STMY1 Mouse P28862 MMP-7 MMP7 MPSL1 PUMP1 Mouse AAA99983 MMP-8/Neutrophil collagenase MMP8 Mouse O70138 MMP-9 MMP9 Mouse P41245 Mus m 1, Major urinary 6, Alpha-2U- MUP6 Mouse P02762 globulinGroup 1, BS6. Myeloperoxidase MPO Mouse P11247 NCAM-1/CD56 NCAM1 NCAM Mouse NP_001106675 Neprilysin MME EPN Mouse Q61391 Nope , *Fc Chimera IGDCC4 Mouse Q9EQS9 NOV/CCN3 NOV CCN3 IGFBP9 NOVH Mouse Q64299 NT-4 NTF4 NTF5 Mouse Q80VU4 Oncostatin M (OSM) OSM Mouse P53347.1 GPNMB HGFIN NMB Osteoactivin/GPNMB , *Fc Chimera Mouse Q99P91 UNQ1725/PRO9925 Osteopontin (OPN) SPP1 BNSP OPN PSEC0156 Mouse P10923 Osteoprotegerin/TNFRSF11B , *Fc Chimera TNFRSF11B OCIF OPG Mouse O08712 OX40 Ligand/TNFSF4 TNFSF4 TXGP1 Mouse P43488 P-Cadherin , *Fc Chimera CDH3 CDHP Mouse P10287 PDGF alpha PDGFA Mouse Q99L56 PDGF beta PDGFB Mouse P31240 Pentraxin 2/SAP NPTX2 NARP Mouse P12246 Pentraxin 3/TSG-14 PTX3 TNFAIP5 TSG14 Mouse P48759 Periostin/OSF-2 POSTN OSF2 Mouse Q62009 Persephin PSPN Mouse A1L3Q1 Pigment epithelium-derived factor, PEDF, Caspin, Serpin F1, Stromal cell-derived SERPINF1 Mouse P97298 factor 3, SDF-3.
Load more

Recommended publications
  • Increased Expression of Epidermal Growth Factor Receptor and Betacellulin During the Early Stage of Gastric Ulcer Healing
    505-510 11/6/08 12:55 Page 505 MOLECULAR MEDICINE REPORTS 1: 505-510, 2008 505 Increased expression of epidermal growth factor receptor and betacellulin during the early stage of gastric ulcer healing GEUN HAE CHOI, HO SUNG PARK, KYUNG RYOUL KIM, HA NA CHOI, KYU YUN JANG, MYOUNG JA CHUNG, MYOUNG JAE KANG, DONG GEUN LEE and WOO SUNG MOON Department of Pathology, Institute for Medical Sciences, Chonbuk National University Medical School and the Center for Healthcare Technology Development, Jeonju, Korea Received January 2, 2008; Accepted February 22, 2008 Abstract. Epidermal growth factor receptor (EGFR) is from tissue necrosis triggered by mucosal ischemia, free important for the proliferation and differentiation of gastric radical formation and the cessation of nutrient delivery, which mucosal cells. Betacellulin (BTC) is a novel ligand for EGFR are caused by vascular and microvascular injury such as Since their role is unclear in the ulcer healing process, we thrombi, constriction or other occlusions (2). Tissue necrosis investigated their expression. Gastric ulcers in 30 Sprague- and the release of leukotriene B attract leukocytes and Dawley rats were induced by acetic acid. RT-PCR and macrophages, which release pro-inflammatory cytokines Western blotting were performed to detect EGFR and BTC. (e.g. TNFα, IL-1α, and IL-1ß). These in turn activate local Immunohistochemical studies were performed to detect fibroblasts, endothelial and epithelial cells. Histologically, an EGFR, BTC and proliferating cell nuclear antigen (PCNA). ulcer has two characteristic structures: a distinct ulcer margin The expression of EGFR and the BTC gene was significantly formed by the adjacent non-necrotic mucosa, and granulation increased at 12 h, 24 h and 3 days after ulcer induction tissue composed of fibroblasts, macrophages and proliferating (P<0.05).
    [Show full text]
  • The TNF and TNF Receptor Review Superfamilies: Integrating Mammalian Biology
    Cell, Vol. 104, 487±501, February 23, 2001, Copyright 2001 by Cell Press The TNF and TNF Receptor Review Superfamilies: Integrating Mammalian Biology Richard M. Locksley,*²³k Nigel Killeen,²k The receptors and ligands in this superfamily have and Michael J. Lenardo§k unique structural attributes that couple them directly to *Department of Medicine signaling pathways for cell proliferation, survival, and ² Department of Microbiology and Immunology differentiation. Thus, they have assumed prominent ³ Howard Hughes Medical Institute roles in the generation of tissues and transient microen- University of California, San Francisco vironments. Most TNF/TNFR SFPs are expressed in the San Francisco, California 94143 immune system, where their rapid and potent signaling § Laboratory of Immunology capabilities are crucial in coordinating the proliferation National Institute of Allergy and Infectious Diseases and protective functions of pathogen-reactive cells. National Institutes of Health Here, we review the organization of the TNF/TNFR SF Bethesda, Maryland 20892 and how these proteins have been adapted for pro- cesses as seemingly disparate as host defense and or- ganogenesis. In interpreting this large and highly active Introduction area of research, we have focused on common themes that unite the actions of these genes in different tissues. Three decades ago, lymphotoxin (LT) and tumor necro- We also discuss the evolutionary success of this super- sis factor (TNF) were identified as products of lympho- familyÐsuccess that we infer from its expansion across cytes and macrophages that caused the lysis of certain the mammalian genome and from its many indispens- types of cells, especially tumor cells (Granger et al., able roles in mammalian biology.
    [Show full text]
  • Fog2 Is Critical for Cardiac Function and Maintenance of Coronary Vasculature in the Adult Mouse Heart
    Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart Bin Zhou, … , Sergei G. Tevosian, William T. Pu J Clin Invest. 2009;119(6):1462-1476. https://doi.org/10.1172/JCI38723. Research Article Cardiology Aberrant transcriptional regulation contributes to the pathogenesis of both congenital and adult forms of heart disease. While the transcriptional regulator friend of Gata 2 (FOG2) is known to be essential for heart morphogenesis and coronary development, its tissue-specific function has not been previously investigated. Additionally, little is known about the role of FOG2 in the adult heart. Here we used spatiotemporally regulated inactivation of Fog2 to delineate its function in both the embryonic and adult mouse heart. Early cardiomyocyte-restricted loss of Fog2 recapitulated the cardiac and coronary defects of the Fog2 germline murine knockouts. Later cardiomyocyte-restricted loss ofF og2 (Fog2MC) did not result in defects in cardiac structure or coronary vessel formation. However, Fog2MC adult mice had severely depressed ventricular function and died at 8–14 weeks. Fog2MC adult hearts displayed a paucity of coronary vessels, associated with myocardial hypoxia, increased cardiomyocyte apoptosis, and cardiac fibrosis. Induced inactivation of Fog2 in the adult mouse heart resulted in similar phenotypes, as did ablation of the FOG2 interaction with the transcription factor GATA4. Loss of the FOG2 or FOG2-GATA4 interaction altered the expression of a panel of angiogenesis-related genes. Collectively, our data indicate that FOG2 regulates adult heart function and coronary angiogenesis. Find the latest version: https://jci.me/38723/pdf Research article Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart Bin Zhou,1,2 Qing Ma,1 Sek Won Kong,1 Yongwu Hu,1,3 Patrick H.
    [Show full text]
  • Recombinant Human Betacellulin Promotes the Neogenesis of -Cells
    Recombinant Human Betacellulin Promotes the Neogenesis of ␤-Cells and Ameliorates Glucose Intolerance in Mice With Diabetes Induced by Selective Alloxan Perfusion Koji Yamamoto, Jun-ichiro Miyagawa, Masako Waguri, Reiko Sasada, Koichi Igarashi, Ming Li, Takao Nammo, Makoto Moriwaki, Akihisa Imagawa, Kazuya Yamagata, Hiromu Nakajima, Mitsuyoshi Namba, Yoshihiro Tochino, Toshiaki Hanafusa, and Yuji Matsuzawa Betacellulin (BTC), a member of the epidermal growth factor family, is expressed predominantly in the human pancreas and induces the differentiation of a pancreatic ancreatic ␤-cells are thought to be terminally dif- acinar cell line (AR42J) into insulin-secreting cells, ferentiated cells with little ability to regenerate. suggesting that BTC has a physiologically important However, proliferation of preexisting ␤-cells and role in the endocrine pancreas. In this study, we exam- differentiation of ␤-cells from precursor cells, ined the in vivo effect of recombinant human BTC P (rhBTC) on glucose intolerance and pancreatic mor- mainly residing in the pancreatic duct lining, have been phology using a new mouse model with glucose intoler- demonstrated in some animal models (1–5). Recently, we ance induced by selective alloxan perfusion. RhBTC developed a new mouse model of diabetes induced by selec- (1 µg/g body wt) or saline was injected subcutaneously tive perfusion of alloxan (100 µg/g body wt) during the every day from the day after alloxan treatment. The clamping of the superior mesenteric artery (1). In this model, intraperitoneal glucose tolerance test revealed no dif- glucose intolerance spontaneously resolves after one year ference between rhBTC-treated and rhBTC-untreated because of the proliferation of surviving ␤-cells in the non- glucose-intolerant mice at 2–4 weeks.
    [Show full text]
  • Tools for Cell Therapy and Immunoregulation
    RnDSy-lu-2945 Tools for Cell Therapy and Immunoregulation Target Cell TIM-4 SLAM/CD150 BTNL8 PD-L2/B7-DC B7-H1/PD-L1 (Human) Unknown PD-1 B7-1/CD80 TIM-1 SLAM/CD150 Receptor TIM Family SLAM Family Butyrophilins B7/CD28 Families T Cell Multiple Co-Signaling Molecules Co-stimulatory Co-inhibitory Ig Superfamily Regulate T Cell Activation Target Cell T Cell Target Cell T Cell B7-1/CD80 B7-H1/PD-L1 T cell activation requires two signals: 1) recognition of the antigenic peptide/ B7-1/CD80 B7-2/CD86 CTLA-4 major histocompatibility complex (MHC) by the T cell receptor (TCR) and 2) CD28 antigen-independent co-stimulation induced by interactions between B7-2/CD86 B7-H1/PD-L1 B7-1/CD80 co-signaling molecules expressed on target cells, such as antigen-presenting PD-L2/B7-DC PD-1 ICOS cells (APCs), and their T cell-expressed receptors. Engagement of the TCR in B7-H2/ICOS L 2Ig B7-H3 (Mouse) the absence of this second co-stimulatory signal typically results in T cell B7-H1/PD-L1 B7/CD28 Families 4Ig B7-H3 (Human) anergy or apoptosis. In addition, T cell activation can be negatively regulated Unknown Receptors by co-inhibitory molecules present on APCs. Therefore, integration of the 2Ig B7-H3 Unknown B7-H4 (Mouse) Receptors signals transduced by co-stimulatory and co-inhibitory molecules following TCR B7-H5 4Ig B7-H3 engagement directs the outcome and magnitude of a T cell response Unknown Ligand (Human) B7-H5 including the enhancement or suppression of T cell proliferation, B7-H7 Unknown Receptor differentiation, and/or cytokine secretion.
    [Show full text]
  • Cytokine Nomenclature
    RayBiotech, Inc. The protein array pioneer company Cytokine Nomenclature Cytokine Name Official Full Name Genbank Related Names Symbol 4-1BB TNFRSF Tumor necrosis factor NP_001552 CD137, ILA, 4-1BB ligand receptor 9 receptor superfamily .2. member 9 6Ckine CCL21 6-Cysteine Chemokine NM_002989 Small-inducible cytokine A21, Beta chemokine exodus-2, Secondary lymphoid-tissue chemokine, SLC, SCYA21 ACE ACE Angiotensin-converting NP_000780 CD143, DCP, DCP1 enzyme .1. NP_690043 .1. ACE-2 ACE2 Angiotensin-converting NP_068576 ACE-related carboxypeptidase, enzyme 2 .1 Angiotensin-converting enzyme homolog ACTH ACTH Adrenocorticotropic NP_000930 POMC, Pro-opiomelanocortin, hormone .1. Corticotropin-lipotropin, NPP, NP_001030 Melanotropin gamma, Gamma- 333.1 MSH, Potential peptide, Corticotropin, Melanotropin alpha, Alpha-MSH, Corticotropin-like intermediary peptide, CLIP, Lipotropin beta, Beta-LPH, Lipotropin gamma, Gamma-LPH, Melanotropin beta, Beta-MSH, Beta-endorphin, Met-enkephalin ACTHR ACTHR Adrenocorticotropic NP_000520 Melanocortin receptor 2, MC2-R hormone receptor .1 Activin A INHBA Activin A NM_002192 Activin beta-A chain, Erythroid differentiation protein, EDF, INHBA Activin B INHBB Activin B NM_002193 Inhibin beta B chain, Activin beta-B chain Activin C INHBC Activin C NM005538 Inhibin, beta C Activin RIA ACVR1 Activin receptor type-1 NM_001105 Activin receptor type I, ACTR-I, Serine/threonine-protein kinase receptor R1, SKR1, Activin receptor-like kinase 2, ALK-2, TGF-B superfamily receptor type I, TSR-I, ACVRLK2 Activin RIB ACVR1B
    [Show full text]
  • Serum Protein Fingerprinting by PEA Immunoassay Coupled with a Pattern-Recognition Algorithms Distinguishes MGUS and Multiple Myeloma
    www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 41), pp: 69408-69421 Research Paper Serum protein fingerprinting by PEA immunoassay coupled with a pattern-recognition algorithms distinguishes MGUS and multiple myeloma Petra Schneiderova1,*, Tomas Pika2,*, Petr Gajdos3, Regina Fillerova1, Pavel Kromer3, Milos Kudelka3, Jiri Minarik2, Tomas Papajik2, Vlastimil Scudla2 and Eva Kriegova1 1Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic 2Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic 3Department of Computer Science, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, Ostrava, Czech Republic *These authors have contributed equally to this work Correspondence to: Eva Kriegova, email: [email protected] Keywords: serum pattern, cytokines, growth factors, proximity extension immunoassay, post-transplant serum pattern Received: May 04, 2016 Accepted: July 28, 2016 Published: August 12, 2016 Copyright: Schneiderova et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Serum protein fingerprints associated with MGUS and MM and their changes in MM after autologous stem cell transplantation (MM-ASCT, day 100) remain unexplored. Using highly-sensitive Proximity Extension ImmunoAssay on 92 cancer biomarkers (Proseek Multiplex, Olink), enhanced serum levels of Adrenomedullin (ADM, Pcorr= .0004), Growth differentiation factor 15 (GDF15, Pcorr= .003), and soluble Major histocompatibility complex class I-related chain A (sMICA, Pcorr= .023), all prosurvival and chemoprotective factors for myeloma cells, were detected in MM comparing to MGUS.
    [Show full text]
  • Supplemental Materials ZNF281 Enhances Cardiac Reprogramming
    Supplemental Materials ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression Huanyu Zhou, Maria Gabriela Morales, Hisayuki Hashimoto, Matthew E. Dickson, Kunhua Song, Wenduo Ye, Min S. Kim, Hanspeter Niederstrasser, Zhaoning Wang, Beibei Chen, Bruce A. Posner, Rhonda Bassel-Duby and Eric N. Olson Supplemental Table 1; related to Figure 1. Supplemental Table 2; related to Figure 1. Supplemental Table 3; related to the “quantitative mRNA measurement” in Materials and Methods section. Supplemental Table 4; related to the “ChIP-seq, gene ontology and pathway analysis” and “RNA-seq” and gene ontology analysis” in Materials and Methods section. Supplemental Figure S1; related to Figure 1. Supplemental Figure S2; related to Figure 2. Supplemental Figure S3; related to Figure 3. Supplemental Figure S4; related to Figure 4. Supplemental Figure S5; related to Figure 6. Supplemental Table S1. Genes included in human retroviral ORF cDNA library. Gene Gene Gene Gene Gene Gene Gene Gene Symbol Symbol Symbol Symbol Symbol Symbol Symbol Symbol AATF BMP8A CEBPE CTNNB1 ESR2 GDF3 HOXA5 IL17D ADIPOQ BRPF1 CEBPG CUX1 ESRRA GDF6 HOXA6 IL17F ADNP BRPF3 CERS1 CX3CL1 ETS1 GIN1 HOXA7 IL18 AEBP1 BUD31 CERS2 CXCL10 ETS2 GLIS3 HOXB1 IL19 AFF4 C17ORF77 CERS4 CXCL11 ETV3 GMEB1 HOXB13 IL1A AHR C1QTNF4 CFL2 CXCL12 ETV7 GPBP1 HOXB5 IL1B AIMP1 C21ORF66 CHIA CXCL13 FAM3B GPER HOXB6 IL1F3 ALS2CR8 CBFA2T2 CIR1 CXCL14 FAM3D GPI HOXB7 IL1F5 ALX1 CBFA2T3 CITED1 CXCL16 FASLG GREM1 HOXB9 IL1F6 ARGFX CBFB CITED2 CXCL3 FBLN1 GREM2 HOXC4 IL1F7
    [Show full text]
  • Human B-Cell Proliferation and Intracellular Signaling: Part 3
    1872 Diabetes Volume 64, June 2015 Andrew F. Stewart,1 Mehboob A. Hussain,2 Adolfo García-Ocaña,1 Rupangi C. Vasavada,1 Anil Bhushan,3 Ernesto Bernal-Mizrachi,4 and Rohit N. Kulkarni5 Human b-Cell Proliferation and Intracellular Signaling: Part 3 Diabetes 2015;64:1872–1885 | DOI: 10.2337/db14-1843 This is the third in a series of Perspectives on intracel- signaling pathways in rodent and human b-cells, with lular signaling pathways coupled to proliferation in pan- a specific focus on the links between b-cell proliferation creatic b-cells. We contrast the large knowledge base in and intracellular signaling pathways (1,2). We highlight rodent b-cells with the more limited human database. what is known in rodent b-cells and compare and contrast With the increasing incidence of type 1 diabetes and that to the current knowledge base in human b-cells. In- the recognition that type 2 diabetes is also due in part variably, the human b-cell section is very brief compared fi b to a de ciency of functioning -cells, there is great ur- with the rodent counterpart, reflecting the still primitive gency to identify therapeutic approaches to expand hu- state of our understanding of mitogenic signaling in hu- b man -cell numbers. Therapeutic approaches might man b-cells. To emphasize this difference, each figure is include stem cell differentiation, transdifferentiation, or divided into two panels, one summarizing rodent b-cell expansion of cadaver islets or residual endogenous signaling and one for human b-cells. Our intended audi- b-cells. In these Perspectives, we focus on b-cell ence includes trainees in b-cell regeneration as well as proliferation.
    [Show full text]
  • Supplementary Material
    Supplementary Material Table S1: Significant downregulated KEGGs pathways identified by DAVID following exposure to five cinnamon- based phenylpropanoids (p < 0.05). p-value Term: Genes (Benjamini) Cytokine-cytokine receptor interaction: FASLG, TNFSF14, CXCL11, IL11, FLT3LG, CCL3L1, CCL3L3, CXCR6, XCR1, 2.43 × 105 RTEL1, CSF2RA, TNFRSF17, TNFRSF14, CCNL2, VEGFB, AMH, TNFRSF10B, INHBE, IFNB1, CCR3, VEGFA, CCR2, IL12A, CCL1, CCL3, CXCL5, TNFRSF25, CCR1, CSF1, CX3CL1, CCL7, CCL24, TNFRSF1B, IL12RB1, CCL21, FIGF, EPO, IL4, IL18R1, FLT1, TGFBR1, EDA2R, HGF, TNFSF8, KDR, LEP, GH2, CCL13, EPOR, XCL1, IFNA16, XCL2 Neuroactive ligand-receptor interaction: OPRM1, THRA, GRIK1, DRD2, GRIK2, TACR2, TACR1, GABRB1, LPAR4, 9.68 × 105 GRIK5, FPR1, PRSS1, GNRHR, FPR2, EDNRA, AGTR2, LTB4R, PRSS2, CNR1, S1PR4, CALCRL, TAAR5, GABRE, PTGER1, GABRG3, C5AR1, PTGER3, PTGER4, GABRA6, GABRA5, GRM1, PLG, LEP, CRHR1, GH2, GRM3, SSTR2, Chlorogenic acid Chlorogenic CHRM3, GRIA1, MC2R, P2RX2, TBXA2R, GHSR, HTR2C, TSHR, LHB, GLP1R, OPRD1 Hematopoietic cell lineage: IL4, CR1, CD8B, CSF1, FCER2, GYPA, ITGA2, IL11, GP9, FLT3LG, CD38, CD19, DNTT, 9.29 × 104 GP1BB, CD22, EPOR, CSF2RA, CD14, THPO, EPO, HLA-DRA, ITGA2B Cytokine-cytokine receptor interaction: IL6ST, IL21R, IL19, TNFSF15, CXCR3, IL15, CXCL11, TGFB1, IL11, FLT3LG, CXCL10, CCR10, XCR1, RTEL1, CSF2RA, IL21, CCNL2, VEGFB, CCR8, AMH, TNFRSF10C, IFNB1, PDGFRA, EDA, CXCL5, TNFRSF25, CSF1, IFNW1, CNTFR, CX3CL1, CCL5, TNFRSF4, CCL4, CCL27, CCL24, CCL25, CCL23, IFNA6, IFNA5, FIGF, EPO, AMHR2, IL2RA, FLT4, TGFBR2, EDA2R,
    [Show full text]
  • Molecular Mediators of Acute and Chronic Itch in Mouse and Human Sensory Neurons Manouela Valtcheva Washington University in St
    Washington University in St. Louis Washington University Open Scholarship Arts & Sciences Electronic Theses and Dissertations Arts & Sciences Spring 5-15-2018 Molecular Mediators of Acute and Chronic Itch in Mouse and Human Sensory Neurons Manouela Valtcheva Washington University in St. Louis Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds Part of the Neuroscience and Neurobiology Commons Recommended Citation Valtcheva, Manouela, "Molecular Mediators of Acute and Chronic Itch in Mouse and Human Sensory Neurons" (2018). Arts & Sciences Electronic Theses and Dissertations. 1596. https://openscholarship.wustl.edu/art_sci_etds/1596 This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open Scholarship. It has been accepted for inclusion in Arts & Sciences Electronic Theses and Dissertations by an authorized administrator of Washington University Open Scholarship. For more information, please contact [email protected]. WASHINGTON UNIVERSITY IN ST. LOUIS Division of Biology and Biomedical Sciences Neurosciences Dissertation Examination Committee: Robert W. Gereau, IV, Chair Yu-Qing Cao Sanjay Jain Qin Liu Durga Mohapatra Molecular Mediators of Acute and Chronic Itch in Mouse and Human Sensory Neurons by Manouela Vesselinova Valtcheva A dissertation presented to The Graduate School of Washington University in partial fulfillment of the requirements for the degree of Doctor of Philosophy May 2018 St. Louis, Missouri © 2018, Manouela V. Valtcheva Table
    [Show full text]
  • Angiocrine Endothelium: from Physiology to Cancer Jennifer Pasquier1,2*, Pegah Ghiabi2, Lotf Chouchane3,4,5, Kais Razzouk1, Shahin Rafi3 and Arash Rafi1,2,3
    Pasquier et al. J Transl Med (2020) 18:52 https://doi.org/10.1186/s12967-020-02244-9 Journal of Translational Medicine REVIEW Open Access Angiocrine endothelium: from physiology to cancer Jennifer Pasquier1,2*, Pegah Ghiabi2, Lotf Chouchane3,4,5, Kais Razzouk1, Shahin Rafi3 and Arash Rafi1,2,3 Abstract The concept of cancer as a cell-autonomous disease has been challenged by the wealth of knowledge gathered in the past decades on the importance of tumor microenvironment (TM) in cancer progression and metastasis. The sig- nifcance of endothelial cells (ECs) in this scenario was initially attributed to their role in vasculogenesis and angiogen- esis that is critical for tumor initiation and growth. Nevertheless, the identifcation of endothelial-derived angiocrine factors illustrated an alternative non-angiogenic function of ECs contributing to both physiological and pathological tissue development. Gene expression profling studies have demonstrated distinctive expression patterns in tumor- associated endothelial cells that imply a bilateral crosstalk between tumor and its endothelium. Recently, some of the molecular determinants of this reciprocal interaction have been identifed which are considered as potential targets for developing novel anti-angiocrine therapeutic strategies. Keywords: Angiocrine, Endothelium, Cancer, Cancer microenvironment, Angiogenesis Introduction of blood vessels in initiation of tumor growth and stated Metastatic disease accounts for about 90% of patient that in the absence of such angiogenesis, tumors can- mortality. Te difculty in controlling and eradicating not expand their mass or display a metastatic phenotype metastasis might be related to the heterotypic interaction [7]. Based on this theory, many investigators assumed of tumor and its microenvironment [1].
    [Show full text]